#7cbde1_Small_Sep-Oct 2024 DRA Journal Cover

The latest DRA Journal issue showcases Asia's dental innovation, featuring Thailand's pioneering stem cell research, advanced clinical techniques like 3D-printed dentures for senior patients and digital workflows for implant restorations, a review of top Asian dental startups, and strategies for improving dental practice culture.

>> FlipBook Version (Available in English)

>> Mobile-Friendly Version (Available in Multiple Languages)

Click here to access Asia's first Open-Access, Multi-Language Dental Publication

ZimVie Launches GenTek Dental Components in US Market

ZimVie, a global leader in dental implant technology, has announced the launch of its GenTek Genuine Restorative Components in the United States. This expansion comes after the company received FDA 510(k) clearance for the product portfolio, which has already seen significant success in the European market since its introduction in 2019.

Comprehensive Prosthetic Solutions

The GenTek portfolio offers a wide range of restorative components designed to support digitally driven CAD/CAM restorations. These include Ti-Bases, pre-milled abutment blanks, screws, instruments, and ancillary products. Manufactured to be compatible with ZimVie’s implant systems, these components aim to ensure a precise fit and tight seal, crucial for long-term aesthetic and functional restorations.

Read: Osstem Implant Co. in Advanced Talks to Acquire ZimVie

Digital Workflow Integration

GenTek’s product line is designed to integrate seamlessly with digital workflows, offering components that are compatible with popular systems such as CEREC. This integration supports the growing trend towards digital dentistry and patient-specific restorations.

Indraneel Kanaglekar, SVP and chief commercial officer at ZimVie, expressed enthusiasm about the launch, stating, “We’re excited to expand our product portfolio with the introduction of GenTek premium prosthetic components, enabling digital workflows and patient-specific restorations for U.S. customers.”

Market Potential and Expectations

The introduction of GenTek to the US market is a significant move for ZimVie, as the United States represents the largest market the company serves. Kanaglekar added, “We have received excellent feedback and strong demand for GenTek in the European market, and we are optimistic that this product suite will be well received here in the U.S.”

About ZimVie

ZimVie, headquartered in Palm Beach Gardens, Florida, is a global life sciences company specializing in dental implants and related technologies. The company focuses on developing and manufacturing products that support tooth replacement and restoration procedures, with a commitment to advancing clinical science and technology in the field of restorative dentistry.

Read: Zimvie Evaluates Sale Following Multiple Takeover Approaches: Bloomberg

Looking Ahead

While the launch of GenTek in the US market represents a significant milestone for ZimVie, the company has included a cautionary note regarding forward-looking statements. As with any new product introduction, actual outcomes may differ from expectations due to various risks and uncertainties in the medical device industry.

The dental community will be watching closely to see how GenTek performs in the competitive US market and whether it can replicate its European success on American soil.

The information and viewpoints presented in the above news piece or article do not necessarily reflect the official stance or policy of Dental Resource Asia or the DRA Journal. While we strive to ensure the accuracy of our content, Dental Resource Asia (DRA) or DRA Journal cannot guarantee the constant correctness, comprehensiveness, or timeliness of all the information contained within this website or journal.

Please be aware that all product details, product specifications, and data on this website or journal may be modified without prior notice in order to enhance reliability, functionality, design, or for other reasons.

The content contributed by our bloggers or authors represents their personal opinions and is not intended to defame or discredit any religion, ethnic group, club, organisation, company, individual, or any entity or individual.

Leave a Reply

Your email address will not be published. Required fields are marked *